Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 9/20 | 0.68 |
| ▸ | OPRM1 | P35372 | 8/20 | 0.68 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.68 |
| ▸ | QRFPR | Q96P65 | 1/20 | 0.57 |
| ▸ | CTSB | P07858 | 1/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.53 |
| ▸ | APC | P25054 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29658002 | 0.87 | OPRD1 (0.56) | OPRD1OPRM1OPRK1CTSB | |
| SCHEMBL31257018 | 0.87 | OPRD1 (0.60) | OPRD1OPRM1OPRK1 | |
| SCHEMBL25627280 | 0.86 | REN (0.61) | OPRD1OPRM1PTPN1 | |
| [Leu5]Enkephalin SCHEMBL29687098 | 0.85 | OPRD1 (0.67) | OPRD1OPRM1OPRK1 | |
| [Leu5]Enkephalin SCHEMBL17951964 | 0.85 | OPRD1 (0.67) | OPRD1OPRM1OPRK1 | |
| SCHEMBL29789592 | 0.85 | CTSB (0.64) | OPRD1OPRM1OPRK1CTSB | |
| SCHEMBL30804496 | 0.84 | FOLH1 (0.60) | OPRD1OPRM1OPRK1CTSB | |
| SCHEMBL29904057 | 0.83 | OPRD1 (0.66) | OPRD1OPRM1OPRK1APC | |
| SCHEMBL8983297 | 0.82 | CTSB (0.62) | OPRD1OPRM1OPRK1CTSB | |
| SCHEMBL8983313 | 0.82 | CTSB (0.62) | OPRD1OPRM1OPRK1CTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | LONGEVITY BIOTECH, INC. | 2024-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | SCTR, GIPR, APLNR | OPRD1 501/4885OPRM1 674/4885OPRK1 364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.